MA56506A - Promédicamentà base de succinate, compositions contenant le promédicament de succinate et utilisations associées - Google Patents

Promédicamentà base de succinate, compositions contenant le promédicament de succinate et utilisations associées

Info

Publication number
MA56506A
MA56506A MA056506A MA56506A MA56506A MA 56506 A MA56506 A MA 56506A MA 056506 A MA056506 A MA 056506A MA 56506 A MA56506 A MA 56506A MA 56506 A MA56506 A MA 56506A
Authority
MA
Morocco
Prior art keywords
succinate prodrug
compositions containing
prodrug
succinate
compositions
Prior art date
Application number
MA056506A
Other languages
English (en)
Inventor
Mats Eskil Elmér
Mark Richard Farmery
Matthew Alan Gregory
Alvar Grönberg
Magnus Joakim Hansson
Steven James Moss
Lee Robert Webster
Original Assignee
Abliva Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abliva Ab filed Critical Abliva Ab
Publication of MA56506A publication Critical patent/MA56506A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/30—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Birds (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
MA056506A 2019-06-19 2020-06-18 Promédicamentà base de succinate, compositions contenant le promédicament de succinate et utilisations associées MA56506A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201970384 2019-06-19
DKPA201970382 2019-06-19
DKPA201970383 2019-06-19

Publications (1)

Publication Number Publication Date
MA56506A true MA56506A (fr) 2022-04-27

Family

ID=71130953

Family Applications (1)

Application Number Title Priority Date Filing Date
MA056506A MA56506A (fr) 2019-06-19 2020-06-18 Promédicamentà base de succinate, compositions contenant le promédicament de succinate et utilisations associées

Country Status (11)

Country Link
US (2) US11565998B2 (fr)
EP (2) EP3986862B1 (fr)
JP (2) JP7699551B2 (fr)
KR (1) KR102871719B1 (fr)
CN (1) CN113993842B (fr)
AU (1) AU2020298031B2 (fr)
CA (1) CA3143112A1 (fr)
IL (1) IL288990B2 (fr)
MA (1) MA56506A (fr)
MX (1) MX2021015137A (fr)
WO (1) WO2020254484A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL288990B2 (en) * 2019-06-19 2025-09-01 Abliva Ab Succinate drug meters, preparations containing the succinate drug meters and its uses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9612331D0 (en) 1996-06-13 1996-08-14 Leo Pharm Prod Ltd Chemical compounds
AUPR059400A0 (en) 2000-10-06 2000-11-02 Bar-Ilan University Formaldehyde-releasing prodrugs
EP3129016B1 (fr) 2014-04-08 2018-06-06 Neurovive Pharmaceutical AB Nouveaux composés de succinate perméables à travers les cellules
US10307389B2 (en) 2014-04-08 2019-06-04 Neurovive Pharmaceutical Ab Succinate prodrugs for use in the treatment of lactic acidosis or drug-induced side-effects due to Complex I-related impairment of mitochondrial oxidative phosphorylation
IL288990B2 (en) * 2019-06-19 2025-09-01 Abliva Ab Succinate drug meters, preparations containing the succinate drug meters and its uses

Also Published As

Publication number Publication date
EP4360708A2 (fr) 2024-05-01
AU2020298031A1 (en) 2022-02-03
US20220162162A1 (en) 2022-05-26
KR102871719B1 (ko) 2025-10-15
IL288990B1 (en) 2025-05-01
AU2020298031B2 (en) 2025-12-18
IL288990A (en) 2022-02-01
EP3986862A1 (fr) 2022-04-27
EP3986862C0 (fr) 2024-01-24
JP7699551B2 (ja) 2025-06-27
BR112021024510A2 (pt) 2022-01-18
US11565998B2 (en) 2023-01-31
US20230033294A1 (en) 2023-02-02
CN113993842B (zh) 2024-07-16
EP3986862B1 (fr) 2024-01-24
JP7827801B2 (ja) 2026-03-10
CN113993842A (zh) 2022-01-28
KR20220024780A (ko) 2022-03-03
EP4360708A3 (fr) 2024-12-25
IL288990B2 (en) 2025-09-01
US12162824B2 (en) 2024-12-10
JP2025004155A (ja) 2025-01-14
CA3143112A1 (fr) 2020-12-24
JP2022538009A (ja) 2022-08-31
WO2020254484A1 (fr) 2020-12-24
MX2021015137A (es) 2022-01-18

Similar Documents

Publication Publication Date Title
UA45061S (uk) 1. футляр
MA51288A (fr) Analogues d'incrétine et leurs utilisations
EP3891149A4 (fr) Inhibiteurs de ret, compositions pharmaceutiques et utilisations associées
EP3891148A4 (fr) Inhibiteurs de ret, compositions pharmaceutiques et utilisations associées
EP3737665C0 (fr) Promédicaments à base de kétamine, compositions et utilisations de ceux-ci
MA51287A (fr) Analogues d'incrétine et leurs utilisations
EP3434676A4 (fr) Inhibiteur de cdk pyrrolopyrimidine substituée, composition pharmaceutique le comprenant et son utilisation
EP3880194A4 (fr) Composés deutérés, compositions et utilisations
EP3463277A4 (fr) Formulations de 3-pyrrolidines substituées, compositions contenant celles-ci et leurs utilisations
EP3481414A4 (fr) Formulations d'abaloparatide, timbres transdermiques les contenant, et utilisations de celles-ci
MA49047A (fr) Composés inhibiteurs d'ask1 et utilisations associées
EP3494119A4 (fr) Composés et compositions, et utilisations associées
MX2020011478A (es) Formas solidas de 2-(4-clorofenil)-n-((2-(2,6-dioxopiperidin-3-il) -1-oxoisoindolin-5-il)metil)-2,2-difluoroacetamida y sus composiciones farmaceuticas y usos.
EP3846807A4 (fr) Composés d'imidazoquinoléine et leurs utilisations
EP3415502A4 (fr) Composé hétéroaryle substitué, composition le contenant et application associée
EP3654982A4 (fr) Composés de 1,8-naphthyridinone et leurs utilisations
EP4058568A4 (fr) Vecteurs végétaux, compositions et utilisations associées
EP3436434A4 (fr) Analogues d'indoline et leurs utilisations
EP3709998A4 (fr) Nouveaux composés d'imidazopyrimidine et leurs utilisations
EP3856191A4 (fr) Nouvelles utilisations
EA201990158A1 (ru) Производные бензодиоксана и их фармацевтическое применение
EP3630113A4 (fr) Composition pharmaceutique comprenant un inhibiteur de pde9
MX385910B (es) Composiciones de fragancia que comprenden ciclohexanoato de etilo.
EP3490607A4 (fr) Composés et compositions, et utilisations associées
EP3911324A4 (fr) Composés de 1,8-naphthyridinone et leurs utilisations